P3 Health Partners Inc
NASDAQ:PIII
Relative Value
There is not enough data to reliably calculate the relative value of PIII.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
PIII Competitors Multiples
P3 Health Partners Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
P3 Health Partners Inc
NASDAQ:PIII
|
19.4m USD | 0 | -0.1 | -1.1 | -0.8 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
92.6B USD | 0.2 | 52.3 | 13.6 | 13.6 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
67.4B EUR | 0.3 | 13.1 | 7.7 | 9.8 | |
| US |
|
Cigna Corp
NYSE:CI
|
69.7B USD | 0.3 | 11.7 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
25.1B EUR | 1.1 | 19.9 | 9.4 | 14 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.9B EUR | 1.2 | 23.4 | 9 | 16.7 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.7B USD | 1.6 | 24.7 | 11.9 | 17.2 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.4B USD | 1.9 | 21.6 | 11.8 | 15.8 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.7B EUR | 0.5 | 11 | 5.3 | 9.8 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.5B USD | 11.6 | -27.5 | -30 | -27.3 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.3B USD | 0.8 | 13.8 | 7.2 | 9.7 |